Literature DB >> 11401980

Deletion of wboA enhances activation of the lectin pathway of complement in Brucella abortus and Brucella melitensis.

C M Fernandez-Prada1, M Nikolich, R Vemulapalli, N Sriranganathan, S M Boyle, G G Schurig, T L Hadfield, D L Hoover.   

Abstract

Brucella spp. are gram-negative intracellular pathogens that survive and multiply within phagocytic cells of their hosts. Smooth organisms present O polysaccharides (OPS) on their surface. These OPS help the bacteria avoid the bactericidal action of serum. The wboA gene, coding for the enzyme glycosyltransferase, is essential for the synthesis of O chain in Brucella. In this study, the sensitivity to serum of smooth, virulent Brucella melitensis 16M and B. abortus 2308, rough wboA mutants VTRM1, RA1, and WRR51 derived from these two Brucella species, and the B. abortus vaccine strain RB51 was assayed using normal nonimmune human serum (NHS). The deposition of complement components and mannose-binding lectin (MBL) on the bacterial surface was detected by flow cytometry. Rough B. abortus mutants were more sensitive to the bactericidal action of NHS than were rough B. melitensis mutants. Complement components were deposited on smooth strains at a slower rate compared to rough strains. Deposition of iC3b and C5b-9 and bacterial killing occurred when bacteria were treated with C1q-depleted, but not with C2-depleted serum or NHS in the presence of Mg-EGTA. These results indicate that (i) OPS-deficient strains derived from B. melitensis 16M are more resistant to the bactericidal action of NHS than OPS-deficient strains derived from B. abortus 2308, (ii) both the classical and the MBL-mediated pathways are involved in complement deposition and complement-mediated killing of Brucella, and (iii) the alternative pathway is not activated by smooth or rough brucellae.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11401980      PMCID: PMC98513          DOI: 10.1128/IAI.69.7.4407-4416.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

1.  Phagocytosis and killing of Brucella by human polymorphonuclear leukocytes.

Authors:  E J Young; M Borchert; F L Kretzer; D M Musher
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

2.  Fine structure of A and M antigens from Brucella biovars.

Authors:  P J Meikle; M B Perry; J W Cherwonogrodzky; D R Bundle
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

3.  Molecular characterization of a Brucella species large DNA fragment deleted in Brucella abortus strains: evidence for a locus involved in the synthesis of a polysaccharide.

Authors:  N Vizcaíno; A Cloeckaert; M S Zygmunt; L Fernández-Lago
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

4.  The interaction of Brucella melitensis 16-M and caprine polymorphonuclear leukocytes.

Authors:  M C Gallego; M A Lapeña
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1990       Impact factor: 2.268

5.  Interaction of human complement proteins with serum-sensitive and serum-resistant strains of Escherichia coli.

Authors:  P W Taylor; H P Kroll
Journal:  Mol Immunol       Date:  1984-07       Impact factor: 4.407

6.  Biological properties of RB51; a stable rough strain of Brucella abortus.

Authors:  G G Schurig; R M Roop; T Bagchi; S Boyle; D Buhrman; N Sriranganathan
Journal:  Vet Microbiol       Date:  1991-07       Impact factor: 3.293

7.  Killing of Brucella abortus by bovine serum.

Authors:  L B Corbeil; K Blau; T J Inzana; K H Nielsen; R H Jacobson; R R Corbeil; A J Winter
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

Review 8.  Human brucellosis.

Authors:  E J Young
Journal:  Rev Infect Dis       Date:  1983 Sep-Oct

9.  Bactericidal but not nonbactericidal C5b-9 is associated with distinctive outer membrane proteins in Neisseria gonorrhoeae.

Authors:  K A Joiner; K A Warren; C Hammer; M M Frank
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

10.  Survival of smooth, rough and transposon mutant strains of Brucella abortus in bovine mammary macrophages.

Authors:  R E Price; J W Templeton; L G Adams
Journal:  Vet Immunol Immunopathol       Date:  1990-12       Impact factor: 2.046

View more
  25 in total

1.  Regulation of the mitogen-activated protein kinases by Brucella spp. expressing a smooth and rough phenotype: relationship to pathogen invasiveness.

Authors:  María P Jiménez de Bagüés; Antoine Gross; Annie Terraza; Jacques Dornand
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

2.  Brucella abortus rough mutants induce macrophage oncosis that requires bacterial protein synthesis and direct interaction with the macrophage.

Authors:  Jianwu Pei; Joshua E Turse; Qingmin Wu; Thomas A Ficht
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Brucella melitensis MucR, an orthologue of Sinorhizobium meliloti MucR, is involved in resistance to oxidative, detergent, and saline stresses and cell envelope modifications.

Authors:  A Mirabella; M Terwagne; M S Zygmunt; A Cloeckaert; X De Bolle; J J Letesson
Journal:  J Bacteriol       Date:  2012-11-16       Impact factor: 3.490

4.  Single-molecule interrogation of a bacterial sugar transporter allows the discovery of an extracellular inhibitor.

Authors:  Lingbing Kong; Leon Harrington; Qiuhong Li; Stephen Cheley; Benjamin G Davis; Hagan Bayley
Journal:  Nat Chem       Date:  2013-06-30       Impact factor: 24.427

5.  Immunization of mice with gamma-irradiated Brucella neotomae and its recombinant strains induces protection against virulent B. abortus, B. melitensis, and B. suis challenge.

Authors:  Dina Moustafa; Virendra K Garg; Neeta Jain; Nammalwar Sriranganathan; Ramesh Vemulapalli
Journal:  Vaccine       Date:  2010-11-23       Impact factor: 3.641

6.  CD80/CD28 co-stimulation in human brucellosis.

Authors:  P Skendros; P Boura; F Kamaria; M Raptopoulou-Gigi
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

7.  Brucella abortus rough mutants are cytopathic for macrophages in culture.

Authors:  Jianwu Pei; Thomas A Ficht
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model.

Authors:  D Monreal; M J Grilló; D González; C M Marín; M J De Miguel; I López-Goñi; J M Blasco; A Cloeckaert; I Moriyón
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

9.  Role of the Omp25/Omp31 family in outer membrane properties and virulence of Brucella ovis.

Authors:  Paola Caro-Hernández; Luis Fernández-Lago; María-Jesús de Miguel; Ana I Martín-Martín; Axel Cloeckaert; María-Jesús Grilló; Nieves Vizcaíno
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

10.  Depletion of Complement Enhances the Clearance of Brucella abortus in Mice.

Authors:  Gabriela González-Espinoza; Elías Barquero-Calvo; Esteban Lizano-González; Alejandro Alfaro-Alarcón; Berny Arias-Gómez; Esteban Chaves-Olarte; Bruno Lomonte; Edgardo Moreno; Carlos Chacón-Díaz
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.